Release Date: 31/10/19 17:49 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 295.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%